Compounds > carbapenems
Page last updated: 2024-09-04

carbapenems and Critical Illness

carbapenems has been researched along with Critical Illness in 71 studies

Research

Studies (71)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (7.04)29.6817
2010's40 (56.34)24.3611
2020's26 (36.62)2.80

Authors

AuthorsStudies
Costa, SF; Deo, B; Farrel Côrtes, M; Perdigão, L; Rizek, C; Rodrigues Pires de Campos, L; Santos, S1
Ferreira, AL; Fontes, AMS; Gomides, MDA; Matoso, DC; Sadoyama, G; Silveira, AOSM1
Chen, S; Chen, Z; Guo, J; Li, S; Li, X; Pan, L; Ren, Z; Rui, Z; Tefsen, B; Xu, Q; Yang, G; Zha, L; Zhang, D; Zou, Y1
Chan, MC; Chen, CM; Chen, WC; Chou, YC; Feng, JY; Peng, CK; Sheu, CC; Wang, SH; Wu, BR; Yang, KY; Zheng, ZR1
Arif, F; Hill, DM; Martin, K; Sultan-Ali, I; Velamuri, SR1
Chan, MC; Chen, CM; Chen, CY; Feng, JY; Liang, SJ; Lin, YC; Peng, CK; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR1
Beiwen, W; Erzhen, C; Qin, Z; Yi, D; Yin, Z; Zhenzhu, M1
Caruso, P; Del Missier, GM; Junior, APN; Praça, APA; Silva, ILAFE1
Chen, F; Gong, X; He, X; Liu, X; Wang, L1
Chan, MC; Chen, CM; Feng, JY; Hsu, HS; Kao, HH; Lin, YC; Lin, YT; Peng, CK; Shen, YC; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR1
Alguacil-Guillén, M; Castro-Martínez, M; Cendejas-Bueno, E; Dahdouh, E; Escosa-García, L; Lázaro-Perona, F; Mingorance, J; Moreno-Ramos, F; Ruiz-Carrascoso, G; Schüffelmann, C1
Shah, BK; Wang, C; Wang, J; Xie, S; Xiong, J; Zhao, J1
Katip, W; Nampuan, T; Oberdorfer, P; Rayanakorn, A; Taruangsri, P1
Jiang, J; Liu, X; Long, Y; Qiao, L; Wang, Q; Wu, J; Xu, T; Yang, Y; Yu, J; Zhang, B; Zuo, W1
Dai, Y; Gu, F; Meng, T; Pan, T; Qu, H; Shen, Z; Tan, R; Wang, X; Wu, J; Zhang, L1
Jang, SM; Mueller, BA; Pai, MP; Shaw, AR1
Brüggemann, RJ; de Wildt, SN; Dia, N; Hartman, SJF; Orriëns, L; Schreuder, MF1
Cotta, MO; Dulhunty, JM; Eriksson, L; Harris, P; Malacova, E; Milinovich, GJ; Vickers, ML1
Bouza, E; Burillo, A; Muñoz, P1
Patrier, J; Timsit, JF1
Anastassiou, ED; Assimakopoulos, SF; Christofidou, M; Fligou, F; Karamouzos, V; Kolonitsiou, F; Marangos, M; Papachristou, E; Papadimitriou-Olivgeris, M; Solomou, A; Spiliopoulou, I; Spyropoulou, A; Vamvakopoulou, S1
Baker, S; Barbosa, LS; Boinett, CJ; Croda, J; da Silva, KE; Nguyen, TNT; Simionatto, S; Tetila, A1
Dimov, S; Mitov, I; Stratev, A; Strateva, T; Tanova, R1
Ding, B; Hao, M; Hu, F; Qin, X; Wang, M; Wu, S; Xu, X; Yang, F; Yang, Y; Zhu, J1
Andini, R; Antoniadou, A; Bitterman, R; Brill, MJE; Carmeli, Y; Daikos, GL; Daitch, V; Dishon-Benattar, Y; Durante-Mangoni, E; Eliakim-Raz, N; Friberg, LE; Karlsson, MO; Kotsaki, A; Kristoffersson, AN; Leibovici, L; Lellouche, J; Mouton, JW; Nutman, A; Paul, M; Rognås, V; Skiada, A; Theuretzbacher, U1
Akova, M; Cotta, MO; De Bus, L; De Pascale, G; De Smet, K; De Waele, JJ; Depuydt, P; Dhaese, S; Dimopoulos, G; Fujitani, S; Garnacho-Montero, J; Leone, M; Lipman, J; Ostermann, M; Paiva, JA; Roberts, JA; Schouten, J; Sjövall, F; Steen, J; Tabah, A; Timsit, JF; Zahar, JR; Zand, F; Zirpe, K1
Alves, MZO; Asensi, MD; Bandeira, CS; Beck, DS; Cid, PA; Gomes Junior, SCS; Gomes, MZR; Lima, EM; Lourenço, ND; Marques, JA; Pinheiro, LHZ; Rodrigues, CAS; Santos, RQ; Tonhá, JPS1
Bartzavali, C; Christofidou, M; Fligou, F; Georgakopoulou, A; Kolonitsiou, F; Marangos, M; Mplani, V; Papadimitriou-Olivgeris, M; Spiliopoulou, I1
Chan, MC; Chen, CM; Feng, JY; Lin, YC; Lin, YT; Peng, CK; Shen, YC; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR1
Andini, R; Boccia, F; Corcione, A; De Rosa, R; Durante-Mangoni, E; Gagliardi, M; Karruli, A; Murino, P; Patauner, F; Ruocco, G; Sommese, P; Ursi, MP; Zampino, R1
Chang, HT; Chang, SC; Chen, YC; Cheng, A; Chuang, YC; Sheng, WH; Sun, HY; Yang, CJ; Yang, JL1
Amat, T; Cisneros, JM; Garnacho-Montero, J; Gracia-Ahufinger, I; Gutiérrez-Pizarraya, A; Machuca, I; Pérez-Nadales, E; Torre-Cisneros, J; Torre-Giménez, Á1
Gomez-Simmonds, A; McConville, TH; Sullivan, SB; Uhlemann, AC; Whittier, S1
Chang, HL; Chen, HC; Liang, CA; Lin, YC; Lu, PL; Sheu, CC1
Antachopoulos, C; Gritsi-Gerogianni, N; Iosifidis, E; Karampatakis, T; Karapanagiotou, A; Karyoti, A; Roilides, E; Tsakris, A; Tsergouli, K1
Alvares, PA; Arnoni, MV; da Silva, CB; Mimica, MJ; Sáfadi, MAP1
Antoniadou, E; Iosifidis, E; Kontopoulou, K; Malisiovas, N; Malli, E; Metallidis, S; Petinaki, E; Tasioudis, P; Vatopoulos, A1
Castellanos, Á; Frasquet, J; Gordon, M; Martín, M; Ramirez, P; Ruiz, J; Sánchez, MÁ; Villarreal, E1
Falagas, ME; Lourida, P; Poulikakos, P; Rafailidis, PI; Tansarli, GS1
Amaya-Villar, R; Artero-González, ML; Bautista-Paloma, J; Corcia-Palomo, Y; Espejo-Gutiérrez de Tena, E; Garnacho-Montero, J; Gutiérrez-Pizarraya, A1
Karvouniaris, M; Makris, D; Manoulakas, E; Mantzarlis, K; Zakynthinos, E1
Chong, YP; Choo, EJ; Chung, JW; Jeon, MH; Kim, DM; Kim, T; Kim, YS; Lee, HK; Moon, C; Park, SY; Peck, KR1
Andrasevic, AT; Butic, I; Goic-Barisic, I; Jelic, M; Novak, A; Radic, M; Rubic, Z; Tonkic, M1
Baud, FJ; Deye, N; Marcadé, G; Mégarbane, B; Raskine, L; Rousseau, H; Vicaut, E; Vodovar, D1
Bulitta, JB; Dunlop, R; Hayashi, Y; Jarrett, P; Lassig-Smith, M; Lipman, J; Roberts, JA; Roberts, NA; Starr, T; Stuart, J; Udy, AA; Wallis, SC1
Li, J; Mukhopadhyay, A; Tambyah, PA; Vasudevan, A; Yuen, EG1
Lowman, W; Schleicher, G1
Decosterd, LA; Eggimann, P; Fournier, A; Marchetti, O; Pagani, JL; Pannatier, A; Que, YA; Revelly, JP; Voirol, P1
Bass, SN; Bauer, SR; Lam, SW; Neuner, EA1
Hawari, FI; Le, J; Nazer, LH; Rihani, S1
Abd Rahman, AN; Abdul-Aziz, MH; Lipman, J; Mat-Nor, MB; Roberts, JA; Staatz, CE; Sulaiman, H; Wallis, SC1
Aguilar, L; Gilsanz, F; Gimenez, MJ; Maseda, E1
Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC1
Kays, MB; Lewis, SJ; Mueller, BA1
Bar-Lavie, Y; Dickstein, Y; Dror, T; Edelman, R; Hussein, K; Paul, M1
Asuphon, O; Houngsaitong, J; Kiratisin, P; Montakantikul, P; Sonthisombat, P1
Akova, M; Metan, G1
Abraham, P; Chaar, M; Chester, K; Curzio, K; Huang, V; Lockwood, A; Lodise, TP; Morse, B; Pai, MP; Patka, J; Rabinovich, M; Rahbar, AJ; Salomone, J; Williams, B1
Ambrose, PG; Andes, DR; Bhavnani, SM; Van Wart, SA1
Donaldson, AD; Fisher, DA; Liang, LJ; Razak, L; Tambyah, PA1
Chalevelakis, G; Damala, M; Falagas, ME; Michalopoulos, A; Rafailidis, P; Virtzili, S1
Goto, K; Hagiwara, S; Hidaka, S; Iwasaka, H; Noguchi, T1
Lin, R; Nandy, P; Samtani, MN1
Flamm, R; Kaniga, K; Nandy, P; Samtani, MN1
Abe, T; Goto, K; Hagiwara, S; Hidaka, S; Nishida, T; Noguchi, T; Ohchi, Y; Shitomi, R; Yamamoto, S; Yasuda, N1
De Waele, JJ; Lipman, J; Paterson, DL; Roberts, JA; Udy, AA1
Aeinlang, N; Jaruratanasirikul, S; Jullangkoon, M; Kositpantawong, N; Wongpoowarak, W1
Lipman, J; Roberts, JA1
Cecchini, L; Chinello, P; Esposito, S; Franchi, C; Masala, M; Nicastri, E; Petrosillo, N; Proietti, MF; Venditti, M1
Baraniak, A; Bossaert, L; Demey, HE; Gniadkowski, M; Goethaert, K; Goossens, H; Ieven, M; Jansens, H; Jorens, PG; Lammens, C; Van Herck, K; Van Looveren, M1
Ariza, J; Dominguez, MA; Gudiol, F; Guzmán, A; Peña, C; Pujol, M; Suarez, C; Tubau, F1

Reviews

8 review(s) available for carbapenems and Critical Illness

ArticleYear
Meropenem for the Pharmacological Treatment of Severe Infections in Critically Ill Pediatric Patients: Breakthrough Standard Treatment Strategies Based on PK/PD.
    Current drug metabolism, 2023, Volume: 24, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Child; Critical Illness; Humans; Meropenem

2023
Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.
    Clinical pharmacokinetics, 2020, Volume: 59, Issue:2

    Topics: Acute Kidney Injury; Adolescent; Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Cephalosporins; Child; Child, Preschool; Critical Illness; Drug Monitoring; Female; Half-Life; Humans; Infant; Infusions, Intravenous; Male; Penicillins; Vancomycin; Young Adult

2020
Modifiable risk factors for multidrug-resistant Gram-negative infection in critically ill burn patients: a systematic review and meta-analysis.
    ANZ journal of surgery, 2019, Volume: 89, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Drug Resistance, Multiple; Gram-Negative Bacterial Infections; Humans; Hydrotherapy; Intensive Care Units; Penicillins; Respiration, Artificial; Risk Factors; Urinary Catheters; Vascular Access Devices

2019
Risk stratification for multidrug-resistant Gram-negative infections in ICU patients.
    Current opinion in infectious diseases, 2019, Volume: 32, Issue:6

    Topics: beta-Lactam Resistance; Carbapenems; Carrier State; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Mass Screening; Prognosis; Risk Assessment; Risk Factors

2019
Carbapenem use in critically ill patients.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:1

    Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteria; beta-Lactam Resistance; Carbapenems; Critical Illness; Humans; Intensive Care Units; Prescription Drug Overuse; Sepsis

2020
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Critical Illness; Drug Therapy, Combination; Enterobacteriaceae; Humans; Minocycline; Pneumonia, Bacterial; Survival Analysis; Tigecycline; Urinary Tract Infections

2014
Basis for selecting optimum antibiotic regimens for secondary peritonitis.
    Expert review of anti-infective therapy, 2016, Volume: 14, Issue:1

    Topics: Abdominal Cavity; Anti-Bacterial Agents; Candida; Candidiasis; Carbapenems; Critical Illness; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Minocycline; Peritonitis; Practice Guidelines as Topic; Risk Factors; Tigecycline

2016
Reducing the impact of carbapenem-resistant Enterobacteriaceae on vulnerable patient groups: what can be done?
    Current opinion in infectious diseases, 2016, Volume: 29, Issue:6

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Colistin; Critical Illness; Drug Combinations; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Retrospective Studies; Thienamycins

2016

Trials

6 trial(s) available for carbapenems and Critical Illness

ArticleYear
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:12

    Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans

2020
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Cross Infection; Female; Fosfomycin; Humans; Infusions, Intravenous; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Treatment Outcome

2010
Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bayes Theorem; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Female; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Pneumonia, Bacterial; Pyelonephritis; Renal Insufficiency; Urinary Tract Infections; Young Adult

2010
Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Time Factors

2012
Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
    Critical care medicine, 2013, Volume: 41, Issue:2

    Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Cross Infection; Doripenem; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Intensive Care Units; Male; Middle Aged; Monte Carlo Method; Obesity; Pneumonia, Bacterial

2013
High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Critical Illness; Cross Infection; Drug Therapy, Combination; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome

2006

Other Studies

57 other study(ies) available for carbapenems and Critical Illness

ArticleYear
Risk factors for bloodstream infection by multidrug-resistant organisms in critically ill patients in a reference trauma hospital.
    American journal of infection control, 2022, Volume: 50, Issue:6

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Critical Illness; Drug Resistance, Multiple, Bacterial; Enterococcus; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Risk Factors; Sepsis

2022
The importance of active surveillance of carbapenem-resistant Enterobacterales (CRE) in colonization rates in critically ill patients.
    PloS one, 2022, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Critical Illness; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Retrospective Studies; Young Adult

2022
Clinical management of infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: A nationwide survey of tertiary hospitals in mainland China.
    The Journal of infection, 2022, Volume: 84, Issue:6

    Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Critical Illness; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tertiary Care Centers

2022
The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study.
    Critical care (London, England), 2022, 04-04, Volume: 26, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Gram-Negative Bacteria; Humans; Pneumonia, Bacterial; Retrospective Studies

2022
Analysis of Ceftazidime/Avibactam Use for Treating Carbapenem-Resistant Infections in Critically Ill Patients With Thermal or Inhalation Injuries.
    Journal of burn care & research : official publication of the American Burn Association, 2022, 07-01, Volume: 43, Issue:4

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Burns; Carbapenems; Ceftazidime; Critical Illness; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests

2022
Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study.
    Scientific reports, 2022, 05-07, Volume: 12, Issue:1

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Cross Infection; Gram-Negative Bacteria; Healthcare-Associated Pneumonia; Humans; Retrospective Studies

2022
Characteristics of bloodstream infection and initial antibiotic use in critically ill burn patients and their impact on patient prognosis.
    Scientific reports, 2022, 11-22, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; Burns; Carbapenems; China; Critical Illness; Humans; Klebsiella pneumoniae; Lincomycin; Prognosis; Retrospective Studies; Sepsis

2022
In-hospital mortality and one-year survival of critically ill patients with cancer colonized or not with carbapenem-resistant gram-negative bacteria or vancomycin-resistant enterococci: an observational study.
    Antimicrobial resistance and infection control, 2023, 02-08, Volume: 12, Issue:1

    Topics: Adult; Carbapenems; Critical Illness; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hospital Mortality; Humans; Vancomycin-Resistant Enterococci

2023
Mortality and ventilator dependence in critically ill patients with ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2023, Volume: 56, Issue:4

    Topics: Acinetobacter baumannii; Carbapenems; Critical Illness; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies; Ventilators, Mechanical

2023
Intestinal loads of extended-spectrum beta-lactamase and Carbapenemase genes in critically ill pediatric patients.
    Frontiers in cellular and infection microbiology, 2023, Volume: 13

    Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Critical Illness; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests

2023
Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB.
    BMC infectious diseases, 2023, May-25, Volume: 23, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymyxin B; Polymyxins; Retrospective Studies

2023
Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study.
    Journal of infection and public health, 2023, Volume: 16, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Humans; Propensity Score; Retrospective Studies

2023
Clinical outcomes and safety of intravenous polymyxin B-based treatment in critically ill patients with carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia.
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:2

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Critical Illness; Cross Infection; Healthcare-Associated Pneumonia; Humans; Polymyxin B; Retrospective Studies; Sulbactam; Tigecycline

2023
The ICU-CARB score: a novel clinical scoring system to predict carbapenem-resistant gram-negative bacteria carriage in critically ill patients upon ICU admission.
    Antimicrobial resistance and infection control, 2023, 10-28, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; China; Critical Illness; Gram-Negative Bacteria; Humans; Intensive Care Units

2023
Antibiotic Exposure Profiles in Trials Comparing Intensity of Continuous Renal Replacement Therapy.
    Critical care medicine, 2019, Volume: 47, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials as Topic; Computer Simulation; Continuous Renal Replacement Therapy; Critical Illness; Dose-Response Relationship, Drug; Humans; Models, Biological; Monte Carlo Method

2019
Risk factors for acute kidney injury in critically ill patients with bacteraemia by carbapenem non-susceptible Gram negative bacteria.
    Le infezioni in medicina, 2019, Dec-01, Volume: 27, Issue:4

    Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors

2019
Risk factors for polymyxin-resistant carbapenemase-producing Enterobacteriaceae in critically ill patients: An epidemiological and clinical study.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Critical Illness; Enterobacteriaceae Infections; Humans; Polymyxins; Risk Factors

2020
Clonal spread of carbapenem-resistant
    Infectious diseases (London, England), 2020, Volume: 52, Issue:6

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bulgaria; Carbapenems; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Renal Replacement Therapy

2020
The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.
    The Journal of infectious diseases, 2020, 03-16, Volume: 221, Issue:Suppl 2

    Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Critical Illness; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Nasopharynx; Prospective Studies; Rectum; Risk Factors; Whole Genome Sequencing

2020
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study.
    Intensive care medicine, 2020, Volume: 46, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Critical Illness; Humans; Intensive Care Units

2020
Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Antimicrobial resistance and infection control, 2020, 08-14, Volume: 9, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Case-Control Studies; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Sepsis; Tertiary Care Centers; Young Adult

2020
External validation of INCREMENT-CPE score in a retrospective cohort of carbapenemase-producing Klebsiella pneumoniae bloodstream infections in critically ill patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:6

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cohort Studies; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Retrospective Studies; Sepsis

2021
Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:10

    Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome

2021
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
    Microbial drug resistance (Larchmont, N.Y.), 2021, Volume: 27, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Aspirin; Carbapenems; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Opportunistic Infections; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; SARS-CoV-2; Steroids; Survival Analysis; Treatment Outcome

2021
Should we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple sets?
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Leukopenia; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Severity of Illness Index; Survival Analysis; Thrombocytopenia

2017
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Carbapenems; Cohort Studies; Colistin; Critical Illness; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Propensity Score; Survival Analysis; Tigecycline; Treatment Outcome

2018
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Aged; Aged, 80 and over; Carbapenems; Cephalosporins; Cohort Studies; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Rectum

2017
Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactam Resistance; Carbapenems; Coinfection; Critical Illness; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Severity of Illness Index; Taiwan; Treatment Failure; Treatment Outcome

2018
Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.
    The Journal of hospital infection, 2018, Volume: 99, Issue:4

    Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Epidemiological Monitoring; Female; Gram-Negative Bacterial Infections; Humans; Incidence; Infection Control; Intensive Care Units; Klebsiella pneumoniae; Male; Middle Aged; Non-Randomized Controlled Trials as Topic; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Retrospective Studies; Young Adult

2018
Carbapenem-resistant Gram-negative bloodstream infections in critically ill children: outcome and risk factors in a tertiary teaching hospital in South America.
    The Journal of hospital infection, 2019, Volume: 101, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Critical Illness; Female; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Infant; Male; Risk Factors; South America; Survival Analysis; Tertiary Care Centers; Treatment Outcome

2019
The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.
    Journal of medical microbiology, 2019, Volume: 68, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Critical Illness; Drug Resistance, Bacterial; Female; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Rectum; Risk Factors; Young Adult

2019
Influence of antibiotic pressure on multi-drug resistant
    Antimicrobial resistance and infection control, 2019, Volume: 8

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies

2019
Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
    Chemotherapy, 2013, Volume: 59, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin

2013
Risk factors for the first episode of Klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: a prospective study.
    BioMed research international, 2013, Volume: 2013

    Topics: Adult; Aged; Carbapenems; Colistin; Critical Illness; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Prospective Studies; Risk Factors

2013
Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea.
    Diagnostic microbiology and infectious disease, 2014, Volume: 78, Issue:4

    Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Republic of Korea; Retrospective Studies; Risk Factors

2014
Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia.
    Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Critical Illness; Croatia; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Survival Analysis

2014
Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.
    Infection, 2014, Volume: 42, Issue:4

    Topics: Aged; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Critical Illness; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Middle Aged; Risk Factors

2014
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Plasma; Young Adult

2014
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    BMC infectious diseases, 2014, Nov-25, Volume: 14

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Critical Illness; Cross Infection; Decision Support Techniques; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Risk Factors; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome; Urinary Tract Infections

2014
Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections.
    Diagnostic microbiology and infectious disease, 2015, Volume: 81, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Critical Illness; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult

2015
Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
    Burns : journal of the International Society for Burn Injuries, 2015, Volume: 41, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Surface Area; Burn Units; Burns; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Computer Systems; Critical Illness; Drug Combinations; Drug Monitoring; Female; Humans; Imipenem; Length of Stay; Male; Meropenem; Middle Aged; Retrospective Studies; Thienamycins; Young Adult

2015
Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Critical Illness; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Rate; Systemic Inflammatory Response Syndrome

2015
High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome

2015
Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Prospective Studies; Pseudomonas aeruginosa; Sepsis; Survival Analysis

2016
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
    Critical care (London, England), 2015, Dec-15, Volume: 19

    Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin

2015
Use of Monte Carlo Simulations to Determine Optimal Carbapenem Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
    Journal of clinical pharmacology, 2016, Volume: 56, Issue:10

    Topics: Anti-Bacterial Agents; Body Weight; Carbapenems; Computer Simulation; Critical Illness; Hemofiltration; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Renal Dialysis; Renal Replacement Therapy; Streptococcus pneumoniae

2016
Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    The Journal of hospital infection, 2016, Volume: 94, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Critical Illness; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; Young Adult

2016
Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 50

    Topics: Anti-Bacterial Agents; Carbapenems; Critical Illness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fosfomycin; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thailand

2016
Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients with Sepsis.
    Surgical infections, 2016, Volume: 17, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis; Wounds and Injuries

2016
Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients.
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Clinical Trials as Topic; Computer Simulation; Critical Illness; Doripenem; Female; Humans; Mice

2009
Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Critical Illness; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies

2009
Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF).
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2010, Volume: 130, Issue:1

    Topics: Aged; Aged, 80 and over; Carbapenems; Critical Illness; Doripenem; Female; Half-Life; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Renal Insufficiency

2010
Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method

2010
Effect of hemopurification rate on doripenem pharmacokinetics in critically ill patients receiving high-flow continuous hemodiafiltration.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2011, Volume: 131, Issue:9

    Topics: Aged; Aged, 80 and over; Carbapenems; Chromatography, High Pressure Liquid; Critical Illness; Doripenem; Female; Hemodiafiltration; Humans; Kidney Diseases; Male; Middle Aged; Severity of Illness Index; Time Factors

2011
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:6

    Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Doripenem; Humans; Kidney; Metabolic Clearance Rate; Pneumonia; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic

2012
Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:8

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Rifampin; Treatment Outcome

2005
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Critical Illness; Endemic Diseases; Female; Gastrointestinal Tract; Humans; Imipenem; Incidence; Intensive Care Units; Male; Middle Aged; Pharynx; Pseudomonas aeruginosa; Pseudomonas Infections; Rectum; Risk Factors

2007